InflaRx's Series C Round

InflaRx raised a round of funding on July 21, 2016.

InflaRx is a biopharmaceutical company developing new therapeutics in the terminal complement space. InflaRx focuses on applying its proprietary anti-C5a technology to discover and develop specific in…

Articles about InflaRx's Series C Round: